about
Application of cyclodextrins in antibody microparticles: potentials for antibody protection in spray drying.A comparative study on the physicochemical and biological stability of IgG1 and monoclonal antibodies during spray drying processOptimization of a spray drying process to prepare dry powder microparticles containing plasmid nanocomplex.Encapsulation of ritonavir in solid lipid nanoparticles: in-vitro anti-HIV-1 activity using lentiviral particles.Inhaled sildenafil nanocomposites: lung accumulation and pulmonary pharmacokinetics.Preparation, characterization and optimization of sildenafil citrate loaded PLGA nanoparticles by statistical factorial designD-optimal Design for Preparation and Optimization of Fast Dissolving Bosentan Nanosuspension.Formation and Characterization of Beclomethasone Dipropionate Nanoparticles Using Rapid Expansion of Supercritical SolutionOptimization and characterization of spray-dried IgG formulations: a design of experiment approach.The effective encapsulation of a hydrophobic lipid-insoluble drug in solid lipid nanoparticles using a modified double emulsion solvent evaporation method.Effect of molecular weight and ratio of poly ethylene glycols' derivatives in combination with trehalose on stability of freeze-dried IgG.Loading hydrophilic drug in solid lipid media as nanoparticles: statistical modeling of entrapment efficiency and particle size.Preparation of an Optimized Ciprofloxacin Loaded Chitosan Nanomicelle with Enhanced Antibacterial Activity.Synergistic effect of rSAG1 and rGRA2 antigens formulated in PLGA microspheres in eliciting immune protection against Toxoplasama gondii.The effect of excipients on the stability and aerosol performance of salmon calcitonin dry powder inhalers prepared via the spray freeze drying process.Drying Technologies for the Stability and Bioavailability of BiopharmaceuticalsCysteine proteinase type I, encapsulated in solid lipid nanoparticles induces substantial protection against Leishmania major infection in C57BL/6 miceDelivery of a cocktail DNA vaccine encoding cysteine proteinases type I, II and III with solid lipid nanoparticles potentiate protective immunity against Leishmania major infectionExtraction and preconcentration of salbutamol and terbutaline from aqueous samples using hollow fiber supported liquid membrane containing anionic carrierThe effect of freeze-dried antibody concentrations on its stability in the presence of trehalose and hydroxypropyl-β-cyclodextrin: a Box-Behnken statistical designSystemic delivery of parathyroid hormone (1-34) using spray freeze-dried inhalable particlesThe use of amino acids to prepare physically and conformationally stable spray-dried IgG with enhanced aerosol performanceEffect of amino acids on the stability of spray freeze-dried immunoglobulin G in sugar-based matricesSpray-Freeze Drying: a Suitable Method for Aerosol Delivery of Antibodies in the Presence of Trehalose and CyclodextrinsPorous Microparticles Containing Raloxifene Hydrochloride Tailored by Spray Freeze Drying for Solubility EnhancementApplication of disaccharides alone and in combination, for the improvement of stability and particle properties of spray-freeze dried IgGTopical pentoxifylline for pressure ulcer treatment: a randomised, double-blind, placebo-controlled clinical trialHuman Serum Albumin, a Suitable Candidate to Stabilize Freeze-Dried IgG in Combination with Trehalose: Central Composite DesignFormation of nanosuspensions in bottom-up approach: theories and optimizationDoxorubicin and Anti-PD-L1 Antibody Conjugated Gold Nanoparticles for Colorectal Cancer PhotochemotherapyRespiratory Administration of Infliximab Dry Powder for Local Suppression of InflammationErythropoietin-loaded solid lipid nanoparticles: Preparation, optimization, and in vivo evaluationOptimization of Stable IgG Formulation Containing Amino Acids and Trehalose During Freeze-Drying and After Storage: a Central Composite DesignTadalafil nanocomposites as a dry powder formulation for inhalation, a new strategy for pulmonary arterial hypertension treatmentOptimization of a dry powder inhaler of ciprofloxacin-loaded polymeric nanomicelles by spray drying processImprovement of memory deficits in the rat model of Alzheimer's disease by erythropoietin-loaded solid lipid nanoparticles
P50
Q36301885-71B42CBE-7922-4D70-9979-E043D6E0489CQ37679799-D24A2336-05FF-4788-A8FD-A0AF60A91AFFQ39440010-DEE1E033-CB44-49FB-A2D1-1AB32E568813Q40215796-FCCAEC2E-823F-4A5B-A3F3-2A47EE83E90DQ41275250-73E3869C-11E7-4B75-A3D3-0ED716951F72Q41849535-A29DECB4-ADC9-4C9C-85E7-30BDB80FE253Q42012709-3A2893D6-3A3A-4360-9996-B4D77026D9E3Q42012810-AF2A02B9-2941-48FB-9B4D-4F5BAF3285C4Q45796035-B2D1D526-C512-4837-B429-7348AED287BCQ46223712-81CE1D8E-9F72-4CEA-B130-DDCCEAE410C1Q47201542-3031F0FD-F469-4E38-8702-21A72EC23AC9Q47333517-5905B2C0-D6A1-4A24-BE16-806D80334D12Q49921765-824EEB79-EE2D-49B0-BF1C-83F03E7E61F6Q51121899-753E3D23-E280-4928-BF68-8AF564A2BD09Q51299281-06C62ADA-4C12-45AF-9D80-FDA610227FC7Q58767550-9347CB96-859B-4680-B022-DDAD8D2C34FEQ59274673-1828A84E-70B9-49AD-A273-8628E1928A03Q59274675-DB16D4C0-84B0-4085-92A5-B90F31875902Q83824099-C4D66230-E97F-45A7-9E9F-B9027A6F6AFEQ86884453-EA62802F-1F1F-4877-AB92-7B25FB6E5485Q86981001-BE68C8B7-661F-4926-B627-EB363EE88EF4Q87420217-46C4A0A1-5537-40DA-B757-81248E56FFB3Q88342945-DB93E2DA-B9F7-4687-893F-E04E0F2F1CC2Q88610949-CE4C8E8D-DBC6-483F-AEEB-ECFA9A88F562Q90330840-8DEDC968-7429-4D04-8F33-99469FF75E5CQ90706737-0CD759A6-3553-4837-9791-B458DC9D14B8Q90817282-794248E9-9D50-4487-A18D-94F54B54284DQ90977227-404E3390-B2DA-4969-A78C-EBBDEAC4D7E7Q91126606-3776DD79-6166-4447-96B4-77EC265D52ACQ91278217-BB91F234-E7CC-43DF-BD57-8C1C7F6ACB98Q91950974-C94C91BC-0EA6-47AE-93A0-C5C3390BA97EQ92413469-D73A1154-83BB-4C64-BB4A-A46EA70C424AQ92663900-4F075A23-E4B2-4940-B768-6EAD0A207217Q92891248-B8098637-00E1-4B15-901D-D444BD689854Q93092024-16A4E9DD-E4CF-4649-A699-7C34014E400EQ93166121-02AF97F1-1D90-4306-B543-0A4A6A98BDEC
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
A Vatanara
@en
A Vatanara
@nl
type
label
A Vatanara
@en
A Vatanara
@nl
prefLabel
A Vatanara
@en
A Vatanara
@nl
P31
P496
0000-0002-4293-8633